PGT-A Test

Uses cutting-edge technology to provide single-cell sensitivity.


Research Service

Introducing DiaCarta’s PGT-A Test

Our cutting-edge PGT-A (Preimplantation Genetic Testing for Aneuploidy) test features industry-leading single-cell sensitivity powered by proprietary NGS technology. Even when embryo biopsy samples yield fewer cells, our validated pipeline can still generate high-quality results, minimizing test failures from suboptimal samples. Plus, our streamlined workflow reduces contamination by performing all steps in a single tube.

We look forward to working with IVF or reproductive centers in the US to provide high quality and accuracy test.

Proven expertise with over 400,000 total tests and 100,000+ per year

Global experience testing for patients from over 40 countries

Enhanced detection and analysis of chromosomal mosaicism

A Superior Solution to PGT-A Testing

As a CLIA-certified lab serving the San Francisco Bay Area, our clinic offers the latest advancement in Preimplantation Genetic Testing for Aneuploidy (PGT-A) – an ultra-sensitive next-generation sequencing (NGS) screening of embryo chromosomes before transfer.

PGT-A Test

PGT-A improves IVF success rates by enabling the selection of euploid embryos, reducing miscarriage risk from aneuploid embryos, and providing reassurance of a chromosomally normal pregnancy.

Comprehensive screening

23 pairs of chromosome aneuploidy screening with more than 4M deletion/- duplication, and mosaicism data.

High data accuracy

No change of tubes during analysis prevents data errors caused by potential contamination due to multiple tube switches in the competition’s tests.

As a trusted CLIA-certified laboratory in the San Francisco Bay Area, we combine the latest PGT-A technology with regulatory-compliant processes.